DDrare: Database of Drug Development for Rare Diseases

Iodine (DrugBank: Iodine)

2 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
88	Chronic thromboembolic pulmonary hypertension	1

46. Malignant rheumatoid arthritis [ 4,183 clinical trials, 2,538 drugs, (DrugBank: 401 drugs), 183 drug target genes, 219 drug target pathways]

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 4,183 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000033222	2012/07/01	02/07/2018	Clinical Results of Prophylactic Iodine-supported Primary TKA for Compromised Cases		Osteoarthritis, Rheumatoid arthritis of knee joint	prophylactic iodine-suported primaru TKA	Fukui General Hospital	NULL	Complete: follow-up complete	50years-old	90years-old	Male and Female	30	Not selected	Japan

88. Chronic thromboembolic pulmonary hypertension [ 145 clinical trials, 112 drugs, (DrugBank: 22 drugs), 13 drug target genes, 52 drug target pathways]

Searched query = "Chronic thromboembolic pulmonary hypertension", "CTEPH", "Idiopathic chronic pulmonary thromboembolism"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 145 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03806907 (ClinicalTrials.gov)	April 1, 2019	15/1/2019	Iodine Subtraction Mapping in the Diagnosis of Chronic Pulmonary Thromboembolic Disease	IodiNe Subtraction maPpIng in the Diagnosis of chRonic Pulmonary thromboEmbolic Disease (INSPIRE): An Observational Diagnostic Study	Chronic Thromboembolic Pulmonary Hypertension	Radiation: Computed tomography lung subtraction iodine mapping	University of Sheffield	Sheffield Teaching Hospitals NHS Foundation Trust	Not yet recruiting	18 Years	90 Years	All	100		NULL